Clinical Edge Journal Scan

Prostate cancer: Severe urinary incontinence after surgery is common


 

Key clinical point: More than 9% of men with prostate cancer undergoing radical prostatectomy report a bad urinary incontinence score. Only approximately 9% of these men receive subsequent incontinence surgery.

Major finding: About 5,165 men completed a posttreatment survey after a median time of 18.6 months. A “bad” urinary incontinence score was reported by 9.3% of patients, and 4% also reported having had a big problem with their urinary function. Only 9.1% of patients with "bad" urinary incontinence scores underwent incontinence surgery within 6 months.

Study details: A retrospective study of 11,290 patients with prostate cancer who underwent radical prostatectomy between April 2014 and January 2016.

Disclosures: This work was supported by National Institute of Health Research, Medical Research Council, University College London Hospitals/University College London Comprehensive Biomedical Research Centre, and others. The authors received honoraria, advisory fees, travel expenses, and/or being employed outside this work.

Source: Parry MG et al. BJU Int. 2021 Nov 30. doi: 10.1111/bju.15663 .

Recommended Reading

mCRPC: ARamp is a biomarker candidate for hormone therapy response
Federal Practitioner
mCRPC: Survival with enzalutamide and abiraterone improved in Blacks vs Whites
Federal Practitioner
Clinical Edge Journal Scan Commentary: Prostate Cancer December 2021
Federal Practitioner
Nivolumab-docetaxel shows response in mCRPC
Federal Practitioner
Treatment-related regret is common in localized prostate cancer
Federal Practitioner
Prostate cancer: Patient- and surgeon-level variation in postsurgery sexual function outcomes
Federal Practitioner
Prostate cancer: Grade group 2 is associated with higher treatment rate
Federal Practitioner
Prostate cancer screening: Statins do not modify mortality risk
Federal Practitioner
Prostate cancer: Positive targeted cores increase upgradation risk in active surveillance
Federal Practitioner
Low-grade prostate cancer: Secondary treatment rates slightly higher with delayed surgery
Federal Practitioner